Clinical Trials Directory

Trials / Completed

CompletedNCT02719249

Fabry Disease Screening in ESRD Patients in West of France

Fabry Disease Prevalence in End-stage Renal Disease (ESRD) Patients on Dialysis or Transplant in West of France

Status
Completed
Phase
Study type
Observational
Enrollment
500 (actual)
Sponsor
Rennes University Hospital · Academic / Other
Sex
Male
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

Screening of Fabry disease in end-stage renal disease (ESRD) patients on dialysis or transplant in west of France.

Detailed description

Detection of Fabry disease is done by dried blood spot test, in dialyzed and transplanted men, who reached ESRD for vascular or unknown disease and were not previously screened.

Conditions

Interventions

TypeNameDescription
OTHERDried blood spot test

Timeline

Start date
2016-01-01
Primary completion
2018-06-30
Completion
2018-06-30
First posted
2016-03-25
Last updated
2018-08-28

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02719249. Inclusion in this directory is not an endorsement.